Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Cancer Research
|
August 1, 2019
MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer
Mengyu Xie, Hong Zheng, Ranjna Madan-Lala, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 10, 2013
Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells
Jae-Young Kim, Eric A Welsh, Umut Oguz, et al.
Molecular Oncology
|
November 6, 2025
Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells
Juhyeon Son, Lily L Remsing Rix, Bin Fang, et al.
Cell Chemical Biology
|
November 22, 2016
Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets
Claire E Knezevic, Gabriela Wright, Lily L Remsing Rix, et al.
Methods (San Diego, Calif.)
|
March 19, 2015
Evaluating kinase ATP uptake and tyrosine phosphorylation using multiplexed quantification of chemically labeled and post-translationally modified peptides
Bin Fang, Melissa A Hoffman, Abu-Sayeef Mirza, et al.
Nature Chemical Biology
|
October 2, 2012
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
Georg E Winter, Uwe Rix, Scott M Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2019
HDAC Inhibition Enhances the <i>In Vivo</i> Efficacy of MEK Inhibitor Therapy in Uveal Melanoma
Fernanda Faião-Flores, Michael F Emmons, Michael A Durante, et al.
Molecular Cancer Therapeutics
|
May 20, 2016
PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer
Ankita Jhuraney, Nicholas T Woods, Gabriela Wright, et al.
Cell Chemical Biology
|
July 2, 2019
Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual Targets
Natalia J Sumi, Claudia Ctortecka, Qianqian Hu, et al.
Biorxiv : the Preprint Server for Biology
|
September 10, 2024
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i> -driven lung cancer via concurrent integrin and MET signaling
Qianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Cancer Research
|
August 1, 2019
MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer
Mengyu Xie, Hong Zheng, Ranjna Madan-Lala, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 10, 2013
Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells
Jae-Young Kim, Eric A Welsh, Umut Oguz, et al.
Molecular Oncology
|
November 6, 2025
Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells
Juhyeon Son, Lily L Remsing Rix, Bin Fang, et al.
Cell Chemical Biology
|
November 22, 2016
Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets
Claire E Knezevic, Gabriela Wright, Lily L Remsing Rix, et al.
Methods (San Diego, Calif.)
|
March 19, 2015
Evaluating kinase ATP uptake and tyrosine phosphorylation using multiplexed quantification of chemically labeled and post-translationally modified peptides
Bin Fang, Melissa A Hoffman, Abu-Sayeef Mirza, et al.
Nature Chemical Biology
|
October 2, 2012
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
Georg E Winter, Uwe Rix, Scott M Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2019
HDAC Inhibition Enhances the <i>In Vivo</i> Efficacy of MEK Inhibitor Therapy in Uveal Melanoma
Fernanda Faião-Flores, Michael F Emmons, Michael A Durante, et al.
Molecular Cancer Therapeutics
|
May 20, 2016
PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer
Ankita Jhuraney, Nicholas T Woods, Gabriela Wright, et al.
Cell Chemical Biology
|
July 2, 2019
Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual Targets
Natalia J Sumi, Claudia Ctortecka, Qianqian Hu, et al.
Biorxiv : the Preprint Server for Biology
|
September 10, 2024
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i> -driven lung cancer via concurrent integrin and MET signaling
Qianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Page
of 9